721 Ongoing phase 1 study of MP0317, a FAP-CD40 DARPin, shows a favorable safety profile and early evidence of tumor-localized CD40 activation in patients with advanced solid tumors

Podobné jednotky

• PTT-Mediated Inhibition of Cancer Proliferation and Tumor Progression by DARPin-Coated Gold Nanoparticles
  Autor: Galina M. Proshkina, a další
  Vydáno: (2025-01-01)
• 721 Ongoing phase 1 study of MP0317, a FAP-CD40 DARPin, shows a favorable safety profile and early evidence of tumor-localized CD40 activation in patients with advanced solid tumors
  Autor: Anne Goubier, a další
  Vydáno: (2023-11-01)
• Development of DARPin T cell engagers for specific targeting of tumor-associated HLA/peptide complexes
  Autor: Natalia Venetz-Arenas, a další
  Vydáno: (2025-12-01)
• A Multispecific Checkpoint Inhibitor Nanofitin with a Fast Tumor Accumulation Property and Anti-Tumor Activity in Immune Competent Mice
  Autor: Perrine Jacquot, a další
  Vydáno: (2025-03-01)
• Coxiella burnetii Nine Mile II Δcbu0533 as a suitable laboratory replacement strain
  Autor: Kathleen N. Pierce, a další
  Vydáno: (2026-01-01)